Turn Biotechnologies
Turn Bio’s patented ERA™ Technology Platform enables us to develop tailored, precise and targeted therapies for an array of age-related diseases that affect hundreds of millions of people globally. Turn Bio’s focus is not on traditional palliative therapies, but on the curative regeneration of tissue at the cellular level. Turn Bio’s technology combats the effects of aging in the epigenome by reprogramming cells back to their youthful state. Unlike genetic problems, epigenetic changes are reversible and do not change the DNA sequence. Our technology reverses the effects of aging to restore optimal gene expression, thereby enabling cells to function as vigorously as when they were younger.
